hätte man die news bloss eher gelesen...
aktuell + 50%
(RTTNews.com) - Kindred Healthcare Inc. ( KND ) announced Thursday that it has proposed to acquire all of the outstanding shares of common stock of Gentiva Health Services Inc. ( GTIV ) for a combination of $7.00 per share in cash and $7.00 of Kindred common stock. Kindred also offered to increase its offer to 100% cash if the Gentiva Board so elects.
You'll Love Our Free
KND Analysis
My name is Tracey Ryniec and I'm giving you a detailed report on KND from Zacks Investment Research.
It predicts where that stock will head in 1 to 3 months.The report applies our earnings-based system that nearly tripled the market since 1988.
But KND might not be your best choice. So you will also receive a second report, 5 Stocks to Double with my compliments.
Get free KND analysis and 5 Stocks to Double
Based upon the closing price of Gentiva's common stock on May 14, 2014, Kindred's proposal would provide Gentiva shareholders with consideration currently valued at approximately $14.00 per share, representing a 64% premium over the closing price of Gentiva common stock on May 14, 2014, and a 59% premium over Gentiva's 60-day volume-weighted average closing price.
The proposed price for Gentiva implies a total equity value of approximately $533 million. With the assumption of Gentiva's debt, the transaction would be valued at approximately $1.6 billion.
Read more: www.nasdaq.com/article/...r-14shr-20140515-00188#ixzz31mniGGZS
aktuell + 50%
(RTTNews.com) - Kindred Healthcare Inc. ( KND ) announced Thursday that it has proposed to acquire all of the outstanding shares of common stock of Gentiva Health Services Inc. ( GTIV ) for a combination of $7.00 per share in cash and $7.00 of Kindred common stock. Kindred also offered to increase its offer to 100% cash if the Gentiva Board so elects.
You'll Love Our Free
KND Analysis
My name is Tracey Ryniec and I'm giving you a detailed report on KND from Zacks Investment Research.
It predicts where that stock will head in 1 to 3 months.The report applies our earnings-based system that nearly tripled the market since 1988.
But KND might not be your best choice. So you will also receive a second report, 5 Stocks to Double with my compliments.
Get free KND analysis and 5 Stocks to Double
Based upon the closing price of Gentiva's common stock on May 14, 2014, Kindred's proposal would provide Gentiva shareholders with consideration currently valued at approximately $14.00 per share, representing a 64% premium over the closing price of Gentiva common stock on May 14, 2014, and a 59% premium over Gentiva's 60-day volume-weighted average closing price.
The proposed price for Gentiva implies a total equity value of approximately $533 million. With the assumption of Gentiva's debt, the transaction would be valued at approximately $1.6 billion.
Read more: www.nasdaq.com/article/...r-14shr-20140515-00188#ixzz31mniGGZS
Jeder ist für sein Handeln selbst verantwortlich. Keine Kaufs-/Verkaufsempfehlung !!!
Im Unterschied zur Straßenbahn wird an der Börse zum Ein- und Aussteigen nicht geklingelt.
Im Unterschied zur Straßenbahn wird an der Börse zum Ein- und Aussteigen nicht geklingelt.
